RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.
  3. Financials
  4. Stockholders' equity

ABEONA THERAPEUTICS INC.ABEO

Market cap
$255.78M
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 202444+196.99%
Dec 31, 202315-44.60%
Dec 31, 202227-47.91%
Dec 31, 202151-49.90%
Dec 31, 2020103-42.53%
Dec 31, 2019178+33.11%
Dec 31, 2018134-21.20%
Dec 31, 2017170+71.65%
Dec 31, 201699+46.33%
Dec 31, 201568+1306.17%
Dec 31, 20145-132.59%
Dec 31, 2013-15-13.45%
Dec 31, 2012-17-3.01%
Dec 31, 2011-18

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)